Logo image
Middle East respiratory syndrome and severe acute respiratory syndrome
Journal article   Open access   Peer reviewed

Middle East respiratory syndrome and severe acute respiratory syndrome

Rahul Vijay and Stanley Perlman
Current opinion in virology, Vol.16, pp.70-76
02/2016
DOI: 10.1016/j.coviro.2016.01.011
PMCID: PMC4821769
PMID: 26855039
url
https://doi.org/10.1016/j.coviro.2016.01.011View
Published (Version of record) Open Access

Abstract

The recent emergence of the Middle East respiratory syndrome (MERS)-CoV, a close relative of the Severe Acute respiratory syndrome (SARS)-CoV, both of which caused a lethal respiratory infection in humans, reinforces the need for further understanding of coronavirus pathogenesis and the host immune response. These viruses have evolved diverse strategies to evade and block host immune responses, facilitating infection and transmission. Pathogenesis following infection with these viruses is characterized by a marked delay in the induction of Type I interferon (IFN I) and, subsequently, by a poor adaptive immune response. Therapies that expedite IFN I induction as well as interventions that antagonize immunoevasive virus proteins are thus promising candidates for immune modulation.
T-Lymphocyte Subsets - immunology Disease Susceptibility Severe Acute Respiratory Syndrome - virology Immunomodulation Humans Severe Acute Respiratory Syndrome - immunology Coronavirus Infections - immunology Host-Pathogen Interactions - immunology Coronavirus Infections - transmission Epitopes - immunology Animals Coronavirus Infections - metabolism Coronavirus Infections - virology T-Lymphocyte Subsets - metabolism Severe Acute Respiratory Syndrome - metabolism Middle East Respiratory Syndrome Coronavirus - physiology

Details

Metrics

Logo image